QLGN NASDAQ

Qualigen Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology
$2.33
+0.01 (+0.4%)
2
Quality Score
fail
Mkt Cap
$7.6M
ROE
-258.2%
Margin
-288.5%
D/E
2546.39
Beta
0.23
52W
$2–$9

Price Chart

Fundamentals Trend

Metric 2024-12-31 2025-03-31 2025-06-30 2025-09-02 2025-10-02 2025-11-03
ROE (TTM) -31.9% -258.2% — -258.2% -258.2% -258.2%
P/E (TTM) — — — — — —
Net Margin — — — -288.5% -288.5% -288.5%
Gross Margin — — — 23.1% 23.1% 23.1%
D/E Ratio 0.00 2546.39 — 2546.39 2546.39 2546.39
Current Ratio 2.33 1.01 0.71 1.01 0.71 0.71

Key Ratios

ROA (TTM)
-202.2%
P/S (TTM)
1.25
P/B
1.2
EPS (TTM)
$-8.53
CF/Share
$-4.40
52W High
$8.81
52W Low
$1.61
$1.61 52-Week Range $8.81

How does QLGN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

QLGN AAPG ABEO ABOS ABP

QLGN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.3
▼ 90% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.2
▼ 53% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

QLGN profitability vs Biotechnology peers

ROE
-258.2%
▼ 284% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-288.5%
▼ 1% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
23.1%
▼ 71% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-202.2%
▼ 333% below peers (-46.7%)
vs Peers
vs Industry
Weak

QLGN financial health vs Biotechnology peers

D/E ratio
2546.4
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
0.7
▼ 84% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.2
▼ 76% below peers (1.0)
vs Peers
vs Industry
More volatile

QLGN fundamentals radar

QLGN Peer median Industry

QLGN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

QLGN vs peers: key metrics

Latest News

No related news yet